TGen and Deepcell collaborate to employ AI-based technology to classify and isolate diseased cells - News-Medical.Net
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is partnering with a Silicon Valley firm to become one of the first research institutes in the world to employ a new Artificial Intelligence-powered imaging and sorting technology to classify and isolate individual diseased cells. TGen's Scientific Technology Assessment Research Team (START) is partnering with Menlo Park-based Deepcell, which has developed a novel imaging platform that uses AI to analyze individual live cells in real-time. TGen is the first of a handful of institutions to join Deepcell's Technology Access Program. The technology uses cell imaging and AI to analyze single cell morphology -; essentially what it looks like -; within the context of the other cells in the sample. This enables users that are looking for novel ways to understand cell biology to characterize and isolate cells from minute visual features. Its resolution is powerful enough to see many of the c...